Security
ABT · Abbott Laboratories
40 institutional holder(s) · 40 congressional trade(s)
Abbott Laboratories makes medical devices (FreeStyle Libre glucose monitors), diagnostics, nutrition products (Ensure, Similac), and branded generic drugs. It is held by 12 of 26 tracked funds in the latest quarter and traded by 30 members of Congress in disclosed filings.
Institutional holders
13F
| Fund | Value | Shares |
|---|
| Vanguard Group |
$19.85B | 158,392,863 |
| State Street |
$7.34B | 80,926,234 |
| BlackRock |
$5.4B | 59,511,037 |
| Fidelity |
$4.02B | 14,898,597 |
| Vanguard Group |
$3.89B | 18,219,122 |
| BlackRock |
$3.34B | 36,775,580 |
| Geode Capital Management |
$3.02B | 33,484,908 |
| State Street |
$2.13B | 7,905,748 |
| BlackRock |
$1.49B | 5,519,096 |
| BlackRock |
$1.36B | 15,019,625 |
| Vanguard Group |
$1.22B | 9,715,723 |
| Geode Capital Management |
$1.06B | 3,967,166 |
| BlackRock |
$922.7M | 3,422,580 |
| Morgan Stanley |
$852.5M | 9,395,095 |
| Fidelity |
$799.3M | 2,964,917 |
| Two Sigma Investments |
$737.4M | 8,126,315 |
| Citadel Advisors |
$732.8M | 8,075,751 |
| Morgan Stanley |
$657.4M | 7,245,402 |
| BlackRock |
$551.9M | 6,082,008 |
| Fidelity |
$541.8M | 5,971,086 |
| Bank of America |
$535.8M | 5,905,132 |
| Fidelity |
$521.2M | 1,933,145 |
| Geode Capital Management |
$520.3M | 5,734,429 |
| Bank of America |
$494.1M | 5,445,318 |
| Fidelity |
$477.9M | 5,267,096 |
| Vanguard Group |
$474.4M | 3,786,042 |
| BlackRock |
$466.3M | 5,138,877 |
| BlackRock |
$449M | 4,947,954 |
| BlackRock |
$442.5M | 1,641,469 |
| BlackRock |
$382.1M | 4,210,627 |
| Fidelity |
$371.4M | 1,377,427 |
| Vanguard Group |
$352.4M | 2,812,659 |
| Bank of America |
$347.8M | 3,833,080 |
| BlackRock |
$336.1M | 3,703,590 |
| Millennium Management |
$326.7M | 3,599,994 |
| BlackRock |
$305.3M | 3,364,871 |
| BlackRock |
$287.9M | 3,172,837 |
| BlackRock |
$263.8M | 2,906,841 |
| BlackRock |
$260.1M | 2,866,379 |
| Morgan Stanley |
$250.5M | 2,761,106 |
Congressional trades
STOCK Act